Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$131.57
-0.3%
$131.03
$99.71
$141.23
$228.19B0.75.88 million shs6.24 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$494.61
-2.5%
$550.11
$364.17
$616.00
$176.17B1.431.53 million shs2.73 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$159.90
+2.9%
$159.36
$140.68
$169.99
$385.33B0.477.76 million shs13.24 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$228.60
-7.0%
$256.54
$179.20
$280.25
$639.18B1.19.40 million shs17.16 million shs
Raymond James stock logo
RJF
Raymond James
$130.18
-8.3%
$152.41
$104.24
$174.32
$26.68B1.041.25 million shs2.13 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.30%+4.46%-5.73%+16.45%+17.93%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+2.15%-0.39%-10.57%-3.24%+32.61%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.41%-3.86%-6.98%+7.91%-1.47%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
+1.04%-1.95%-5.44%+2.54%+23.76%
Raymond James stock logo
RJF
Raymond James
+3.15%-1.50%-5.37%-8.20%+10.59%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.862 of 5 stars
2.44.04.24.53.52.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.5432 of 5 stars
3.33.00.04.03.52.51.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.3132 of 5 stars
2.33.04.23.93.22.50.6
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.883 of 5 stars
3.35.04.22.12.72.52.5
Raymond James stock logo
RJF
Raymond James
4.9545 of 5 stars
4.22.02.53.53.61.73.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.944.84% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$611.8623.70% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.337.15% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.53
Moderate Buy$255.0611.58% Upside
Raymond James stock logo
RJF
Raymond James
2.42
Hold$164.6426.47% Upside

Current Analyst Ratings Breakdown

Latest RJF, JPM, ISRG, JNJ, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2025
Raymond James stock logo
RJF
Raymond James
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$198.00 ➝ $173.00
4/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
4/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
4/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$285.00 ➝ $284.00
4/2/2025
Raymond James stock logo
RJF
Raymond James
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $150.00
4/1/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$273.00 ➝ $265.00
3/18/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$707.00 ➝ $600.00
3/17/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/17/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$666.00 ➝ $605.00
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.44$5.67 per share23.22$22.36 per share5.88
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.09$6.51 per share75.93$46.41 per share10.66
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.34$13.14 per share12.17$29.69 per share5.39
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$169.44B3.77$18.86 per share12.12$116.13 per share1.97
Raymond James stock logo
RJF
Raymond James
$13.15B2.03$9.29 per share14.01$57.83 per share2.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.2022.962.5231.95%20.74%11.19%4/16/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.4177.1664.825.8527.81%14.55%12.88%4/22/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.0414.442.5618.20%34.24%13.63%4/15/2025 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$58.47B$19.7411.5811.772.8320.96%16.99%1.31%4/11/2025 (Estimated)
Raymond James stock logo
RJF
Raymond James
$2.07B$10.2512.7010.810.9014.06%19.71%2.74%4/23/2025 (Estimated)

Latest RJF, JPM, ISRG, JNJ, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2025N/A
Raymond James stock logo
RJF
Raymond James
$2.57N/AN/AN/A$3.46 billionN/A
4/22/2025N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71N/AN/AN/A$2.19 billionN/A
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
4/11/2025N/A
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.57N/AN/AN/A$43.62 billionN/A
1/29/2025Q1 2025
Raymond James stock logo
RJF
Raymond James
$2.62$2.93+$0.31$2.86$3.48 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
1/15/2025Q4 2024
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.03$4.81+$0.78$4.81$41.90 billion$42.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.79%+7.17%30.85%54 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.10%+5.43%74.59%63 Years
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$5.602.45%+8.10%28.37%15 Years
Raymond James stock logo
RJF
Raymond James
$2.001.54%+18.21%19.51%N/A

Latest RJF, JPM, ISRG, JNJ, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
3/18/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.38%4/4/20254/4/20254/30/2025
2/21/2025
Raymond James stock logo
RJF
Raymond James
quarterly$0.501.32%4/1/20254/1/20254/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.07
3.22
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.24
0.88
0.89
Raymond James stock logo
RJF
Raymond James
0.35
1.03
1.01

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
71.55%
Raymond James stock logo
RJF
Raymond James
83.83%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
12,100356.18 million352.97 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
293,7002.80 billion2.77 billionOptionable
Raymond James stock logo
RJF
Raymond James
19,000204.91 million203.80 millionOptionable

Recent News About These Companies

Insider Sale: EVP of $NDAQ Sells 2,000 Shares
Bank of America Securities Remains a Buy on Raymond James Financial (RJF)
New Analyst Forecast: $VLO Given 'Strong Buy' Rating
Insider Sale: GC of $ULTA Sells 902 Shares
Insider Sale: SVP of $VEEV Sells 787 Shares
Raymond James price target lowered to $150 from $180 at Citi
Truist Financial cut to Market Perform at Raymond James
$NCNO Earnings Results: $NCNO Reports Quarterly Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$131.57 -0.36 (-0.27%)
Closing price 03:59 PM Eastern
Extended Trading
$130.59 -0.98 (-0.75%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$494.61 -12.44 (-2.45%)
Closing price 04:00 PM Eastern
Extended Trading
$493.05 -1.56 (-0.31%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$159.90 +4.54 (+2.92%)
Closing price 03:59 PM Eastern
Extended Trading
$159.00 -0.89 (-0.56%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

JPMorgan Chase & Co. stock logo

JPMorgan Chase & Co. NYSE:JPM

$228.60 -17.23 (-7.01%)
Closing price 03:59 PM Eastern
Extended Trading
$228.92 +0.32 (+0.14%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

Raymond James stock logo

Raymond James NYSE:RJF

$130.18 -11.71 (-8.25%)
Closing price 03:59 PM Eastern
Extended Trading
$130.48 +0.30 (+0.23%)
As of 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties. The Capital Markets segment offers securities brokerage, trading, and research services to institutions with a focus on sale of the United States and Canadian equities and fixed income products; and manages and participates in underwritings, merger and acquisition services, and public finance activities. The Asset Management segment engages in the operations of Eagle, the Eagle Family of Funds, Cougar, the asset management operations of Raymond James & Associates, trust services of Raymond James Trust, and other fee-based asset management programs. The RJ Bank segment provides corporate loans, SBL, tax-exempt loans, and residential loans. The Other segment engages in private equity activities, including various direct and third party private equity investments; and private equity funds. Raymond James Financial, Inc. was founded in 1962 and is based in St. Petersburg, Florida.